Clearance Summary
BLOOD GROUP SUBSTANCE A,B received FDA 510(k) clearance under submission number K781896, sponsored by North American Biologicals, Inc.. The device was reviewed via the Traditional premarket notification pathway and assigned to the Hematology review panel. The statutory decision date of record is 1978-12-20.
- Submission: K781896
- Applicant / Sponsor: North American Biologicals, Inc.
- Clearance pathway: Traditional
- Review panel: Hematology
- Device class: Class II
- Regulation citation: 21 CFR 864.9160
- Decision date: 1978-12-20
Classification & Regulation
This clearance is catalogued under FDA product code KSX and 21 CFR 864.9160, within the Hematology review panel as a Class II device.